| Business

Become a contributor

Bookmark Econotimes

| Business

JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026

FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement

DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing

BP Nears $10 Billion Castrol Stake Sale to Stonepeak

Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown

Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector

AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study

John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training

Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions

BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands

7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm

Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares

Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program

Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland

Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions

Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling

Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market

©Econometrics LLC . All Rights Reserved.

Immucor to Host Debt Investor Conference Call on Thursday, April 21, 2016

Wednesday, April 13, 2016 1:20 PM UTC

NORCROSS, Ga., April 13, 2016 -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Thursday, April 21, 2016 at 11:00 a.m. ET to discuss its fiscal 2016 third quarter results.

Interested debt investors and analysts should contact Immucor Investor Relations at [email protected] or 770-441-2051 for details.

About Immucor
Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com.

CONTACT: Michele Howard 
770-441-2051

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions

NSW Passes Toughest Gun and Anti-Terror Laws After Bondi Beach Shooting

Japan Plans $189 Billion Bond Issuance as Record Budget Signals Expansionary Fiscal Policy

BOJ Minutes Reveal Growing Debate Over Interest Rate Hikes and Inflation Risks

U.S. Coast Guard Faces Resource Strain as It Pursues Venezuela-Linked Oil Tanker

U.S. Discusses Migrant Transfer Plan With Palau Despite Lawmaker Opposition

BP Nears $10 Billion Castrol Stake Sale to Stonepeak

Democratic Attorneys General Sue Trump Administration Over Proposed Limits on Gender-Affirming Care for Youth

DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

Immucor to Host Debt Investor Conference Call on Thursday, April 21, 2016

Editor's Picks

Welcome to EconoTimes